Autopsy report · NCT03995667

Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Low accrual”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 3 years 2 months before it stopped.
3 participants enrolled.
Results were posted on the registry 1 year 3 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: OHSU Knight Cancer Institute
Sponsor type: University, hospital or other
Conditions: Extensive Stage Lung Small Cell Carcinoma; Limited Stage Lung Small Cell Carcinoma; Stage I Lung Cancer AJCC v8; Stage IA1 Lung Cancer AJCC v8; Stage IA2 Lung Cancer AJCC v8; Stage IA3 Lung Cancer AJCC v8
Interventions: Questionnaire Administration; Tumor Treating Fields Therapy
Participants: 3
Sites: 2
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.